Asensus finalizes name change from TransEnterix, debuts NYSE ticker

Asensus Surgical (NYSE:ASXC) announced today that it formally completed its name and stock ticker change from TransEnterix (NYSE:TRXC).

Research Park Triangle, N.C.-based Asensus announced last month that the company would change its name from TransEnterix to Asensus Surgical and introduce a new surgery category. The company aims to enter a new era of performance-guided surgery focused on digitizing the interface between surgeons and patients to bring clinical intelligence that may enable better outcomes and, potentially, a new standard of surgery.

Effective today, the company’s stock is trading on the New York Stock Exchange American under the ASXC ticker. No actions are needed from current stockholders relative to the change. Shares of ASXC are currently trading at $4.08 per share, having closed yesterday down -10.1%.

Just this week, Asensus garnered its first regulatory nod since the name change, winning expanded FDA clearance for general surger…

Read more
  • March 5, 2021
  • 0

Ra Medical threatened with stock exchange delisting

Ra Medical Systems (NYSE:RMED) announced today that it received notice that is is no longer in compliance with the New York Stock Exchange’s listing standards.

The Carlsbad, Calif.-based company learned that it is not complying with the NYSE continued listing standard that requires companies to maintain an average closing share price of at least $1 over a consecutive 30-trading-day period.

Currently, Ra Medical Systems shares are trading down -4.7% at 45¢ per share in mid-morning trading, standing 55¢ beneath the listing requirement. The company’s common stock must have a closing price of at least $1 per share and an average closing price of at least $1 per share over a 30-trading-day period in order to regain compliance, otherwise, it faces suspension and delisting.

Ra Medical now has a six-month period to regain compliance with the average closing share price requirement. During the COVID-19 pandemic, the NYSE is tolling compliance periods …

Read more
  • May 22, 2020
  • 0